Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion

被引:30
|
作者
Harding, Pamela [1 ]
Yang, Xiao-Ping [1 ]
He, Quan [1 ]
LaPointe, Margot C. [1 ]
机构
[1] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, Detroit, MI 48202 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2011年 / 300卷 / 03期
关键词
microsomal prostaglandin E synthase-1; angiotensin II; hypertrophy; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; MICE LACKING; VENTRICULAR MYOCYTES; PRESSOR-RESPONSE; GENE-EXPRESSION; KNOCKOUT MICE; HYPERTENSION; INHIBITION; RECEPTOR;
D O I
10.1152/ajpheart.00772.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Harding P, Yang XP, He Q, LaPointe MC. Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion. Am J Physiol Heart Circ Physiol 300: H1053-H1061, 2011. First published December 30, 2010; doi: 10.1152/ajpheart.00772.2010.-Our laboratory previously reported that inducible PGE(2) synthase, mPGES-1, contributes to micromolar production of PGE(2) in neonatal ventricular myocytes in vitro, which stimulates their growth. We therefore hypothesized that mPGES-1 contributes to cardiac hypertrophy following angiotensin II (ANG II) infusion. To test this hypothesis, we used 10-to 12-wk-old mPGES-1 knockout mice (mPGES-1 KO) and C57Bl/6 control mice infused for 8 wk with either 1.4 mg.kg(-1).day(-1) ANG II or vehicle subcutaneously. Blood pressure [systolic blood pressure (SBP)] was measured throughout the study, and cardiac function was assessed by M-mode echocardiography at baseline and at 8 wk of infusion. At the conclusion of the study, immunohistochemistry was used to evaluate collagen fraction, myocyte cross-sectional area (MCSA), and apoptosis. At baseline, there was no difference in SBP between mPGES-1 KO mice and C57BL/6 controls. ANG II infusion increased SBP to similar levels in both strains. In control mice, infusion of ANG II increased MCSA and posterior wall thickness at diastole (PWTd) but had little effect on cardiac function, consistent with compensatory hypertrophy. In contrast, cardiac function was worse in mPGES-1 KO mice after ANG II treatment. Ejection fraction declined from 76.2 +/- 2.7 to 63.3 +/- 3.4% after ANG II, and left ventricular dimension at systole and diastole increased from 1.29 +/- 0.02 to 1.78 +/- 0.15 mm and from 2.57 +/- 0.03 to 2.90 +/- 0.13 mm, respectively. Infusion of ANG II increased both the LV-to-body weight and the mass-to-body weight ratios to a similar extent in both strains. However, PWTd increased by a lesser extent in KO mice, suggesting an impaired hypertrophic response. ANG II infusion increased collagen staining similarly in both strains, but TdT-dUTP nick end labeling staining was greater in mPGES-1 KO mice. Overall, these results are consistent with a beneficial effect for mPGES-1 in the maintenance of cardiac function in ANG II-dependent hypertension.
引用
收藏
页码:H1053 / H1061
页数:9
相关论文
共 50 条
  • [1] Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion
    Jia, Zhanjun
    Zhang, Aihua
    Zhang, Hui
    Dong, Zheng
    Yang, Tianxin
    CIRCULATION RESEARCH, 2006, 99 (11) : 1243 - 1251
  • [2] Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1
    Wang, Miao
    FitzGerald, Garret A.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2010, 20 (06) : 189 - 195
  • [3] Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice
    Chen, Lihong
    Yang, Guangrui
    Monslow, James
    Todd, Leslie
    Cormode, David P.
    Tang, Jun
    Grant, Gregory R.
    DeLong, Jonathan H.
    Tang, Soon Yew
    Lawson, John A.
    Pure, Ellen
    FitzGerald, Garret A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (18) : 6828 - 6833
  • [4] Microsomal prostaglandin E synthase-1 and blood pressure regulation
    Yang, T.
    KIDNEY INTERNATIONAL, 2007, 72 (03) : 274 - 278
  • [5] Distribution of Microsomal Prostaglandin E Synthase-1 in the Mouse Brain
    Eskilsson, Anna
    Tachikawa, Masanori
    Hosoya, Ken-Ichi
    Blomqvist, Anders
    JOURNAL OF COMPARATIVE NEUROLOGY, 2014, 522 (14) : 3229 - 3244
  • [6] mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress
    Avendano, Maria S.
    Garcia-Redondo, Ana B.
    Zalba, Guillermo
    Gonzalez-Amor, Maria
    Aguado, Andrea
    Martinez-Revelles, Sonia
    Beltran, Luis M.
    Camacho, Mercedes
    Cachofeiro, Victoria
    Alonso, Maria J.
    Salaices, Mercedes
    Briones, Ana M.
    HYPERTENSION, 2018, 72 (02) : 492 - 502
  • [7] Cell Selective Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1
    Chen, Lihong
    Yang, Guangrui
    Xu, Xiufeng
    Grant, Gregory
    Lawson, John A.
    Bohlooly-Y, Mohammad
    FitzGerald, Garret A.
    CIRCULATION, 2013, 127 (02) : 233 - +
  • [8] Endothelial Microsomal Prostaglandin E Synthase-1 Exacerbates Neuronal Loss Induced by Kainate
    Takemiya, Takako
    Matsumura, Kiyoshi
    Sugiura, Hiroko
    Maehara, Michiyo
    Yasuda, Shin
    Uematsu, Satoshi
    Akira, Shizuo
    Yamagata, Kanato
    JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (02) : 381 - 390
  • [9] Upregulation of prostaglandin E2 by inducible microsomal prostaglandin E synthase-1 in colon cancer
    Kim, Young Hun
    Kim, Kyung Jong
    ANNALS OF COLOPROCTOLOGY, 2022, 38 (02) : 153 - 159
  • [10] Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia
    Chandrasekhar, Srinivasan
    Harvey, Anita K.
    Yu, Xiao-Peng
    Chambers, Mark G.
    Oskins, Jennifer L.
    Lin, Chaohua
    Seng, Thomas W.
    Thibodeaux, Stefan J.
    Norman, Bryan H.
    Hughes, Norman E.
    Schiffler, Matthew A.
    Fisher, Matthew J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (03) : 635 - 644